GLOW
A research blend combining body protection compound, thymosin beta-4 fragment, and copper tripeptide. Studied for combined effects on angiogenesis, collagen synthesis, skin and connective tissue remodeling, and wound healing models.
Unit Price
Sign in to view pricing.
Purchase requires a verified researcher account and a signed RUO attestation.
All batch test results and certificates of analysis are published below — including any batches that failed testing. Full transparency is our standard.
Mechanism of Action
GLOW combines three complementary repair peptides. BPC-157 (Body Protection Compound, a 15-aa gastric peptide) promotes angiogenesis via VEGFR2-PI3K-Akt-eNOS signaling and upregulates growth hormone receptor expression. TB-500 (thymosin beta-4 fragment Ac-LKKTETQ) regulates actin sequestration enabling cell migration in wound repair. GHK-Cu (glycyl-histidyl-lysine copper tripeptide) stimulates collagen, elastin, and glycosaminoglycan synthesis in dermal fibroblasts and modulates MMP/TIMP balance.
Research References
Full research page →Vasireddi N et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. 2025
Philp D et al. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev. 2004. PMID: 15037013
Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018
Pickart L et al. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015
Batch History & Certificates of Analysis
Full Batch Record
Active Batches
BBG70-2026-001
Received Apr 15, 2026
Qty Received
10 units
No test results on record for this batch.
For Research Use Only. This product is supplied exclusively for in vitro research, laboratory study, and experimental purposes. It is not a drug, supplement, food, or cosmetic, and is not intended for human or veterinary use. See our Compliance & RUO Policy.